Tag: CE Mark,EGFR,NSCLC,Non-Small Cell Lung Cancer,Press Releases,Specimen Collection,Veristrat,Veristrat covered,liquid biopsy,lung cancer,oncology,personalized medicine
-
Biodesix Receives CE Mark for VeriStrat Specimen Collection and Shipping Kit
Blood-based protein diagnostic predicts differential treatment outcomes for non-small cell lung cancer